Inventor
ROMERO ARTHUR GLENN
US21 patents
⚠️ This page may combine multiple inventors who share the name “ROMERO ARTHUR GLENN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UPJOHN CO
11 patentsUS6310211B1Oct 30, 2001
8-hydroxy-7-substituted quinolines as anti-viral agents
UPJOHN CO32 citations91
US6211376B1Apr 3, 2001
8-hydroxy-7-substituted quinolines as anti-viral agents
UPJOHN CO17 citations90
US6084130AJul 4, 2000
Aryl substituted bicyclic amines as selective dopamine D3 ligands
UPJOHN CO19 citations79
USRE38452EMar 2, 2004
Heterocyclic amines having central nervous system activity
UPJOHN CO2 citations62
US6103766AAug 15, 2000
Phenylsulfonamide-phenylethylamines useful as dopamine receptors
UPJOHN CO6 citations59
US5650427AJul 22, 1997
Centrally acting 6,7,8,9-tetrahydro-3H-benz(e) indole heterocyclics
UPJOHN CO3 citations55
US6870070B2Mar 22, 2005
Process to prepare 2-aminoindan derivatives
UPJOHN CO0 citations46
US6410787B2Jun 25, 2002
Process to prepare 2-aminoindan derivatives
UPJOHN CO0 citations46
US6576769B2Jun 10, 2003
Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2,3-dihydro-1H-indene-5-carboxamide
UPJOHN CO0 citations45
US6462234B2Oct 8, 2002
Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2, 3-dihydro-1H-indene-5-carboxamide
UPJOHN CO0 citations45
US7022694B2Apr 4, 2006
Indoles and indolines having 5-HT activity
UPJOHN CO0 citations34
MAGENTA THERAPEUTICS INC
3 patentsUS10351572B2Jul 16, 2019
Aryl hydrocarbon receptor antagonists and uses thereof
MAGENTA THERAPEUTICS INC5 citations83
US10457683B2Oct 29, 2019
Aryl hydrocarbon receptor antagonists and uses thereof
MAGENTA THERAPEUTICS INC2 citations72
US10919900B2Feb 16, 2021
Aryl hydrocarbon receptor antagonists and uses thereof
MAGENTA THERAPEUTICS INC1 citations62